More about

Thrombosis

News
March 19, 2025
3 min read
Save

Subclinical cardiac damage evident among cigarette smokers, even quitters

Subclinical cardiac damage evident among cigarette smokers, even quitters

Markers of subclinical heart damage were observed among individuals who smoke cigarettes, even decades after quitting, according to a study published in the Journal of the American College of Cardiology.

News
February 06, 2025
4 min read
Save

Q&A: Lower blood thinner dose can reduce bleeding risk

Q&A: Lower blood thinner dose can reduce bleeding risk

Reduced dosing of direct oral anticoagulants may offer comparable efficacy as full dosing for adults with venous thromboembolism history while decreasing bleeding risk and reducing health care utilization, according to study results.

News
January 27, 2025
2 min read
Save

Top in cardiology: Intermuscular fat linked to CV risk; COVID-19 increased syndrome cases

Top in cardiology: Intermuscular fat linked to CV risk; COVID-19 increased syndrome cases

Researchers found an independent association between increased intermuscular fat, not BMI, and major CV events and coronary microvascular function, according to a study published in the European Heart Journal.

News
January 24, 2025
6 min read
Save

The year in thrombosis, CAD: New PCI populations and DAPT strategies

The year in thrombosis, CAD: New PCI populations and DAPT strategies

Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top developments in thrombosis and coronary disease from 2024.

News
January 22, 2025
3 min read
Save

Targeted therapies for breast cancer increase thrombosis risk

Targeted therapies for breast cancer increase thrombosis risk

SAN DIEGO — The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than reported in prior clinical trials, according to study results.

News
January 22, 2025
2 min read
Save

No cardiovascular risk differences found between biologic treatments for psoriatic disease

No cardiovascular risk differences found between biologic treatments for psoriatic disease

A study found patients treated with interleukin inhibitors did not experience a difference in the rates of major adverse cardiovascular and venous thromboembolic events compared with those treated with tumor necrosis factor inhibitors.

News
January 14, 2025
2 min watch
Save

VIDEO: Type I protein S deficiency may be linked to venous thromboembolism

VIDEO: Type I protein S deficiency may be linked to venous thromboembolism

In this video, Iberia Romina Sosa, MD, PhD, discusses the results of a study presented at ASH Annual Meeting and Exposition, which examined the risk of thrombosis in patients with a protein S deficiency.

News
December 18, 2024
2 min read
Save

Data confirm benefit of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria

Data confirm the safety and efficacy of ravulizumab among patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab, according to results of the REACTION study presented at ASH Annual Meeting and Exposition.

News
December 17, 2024
4 min read
Save

AI model could help identify children at higher risk for blood clots

AI model could help identify children at higher risk for blood clots

An AI model may help identify children at higher risk for developing hospital-acquired venous thromboembolism, according to a presenter at AIMed24 Annual Meeting.

News
December 09, 2024
3 min read
Save

GLP-1s reduce thrombosis risk among people with diabetes, regardless of obesity

GLP-1s reduce thrombosis risk among people with diabetes, regardless of obesity

SAN DIEGO — Glucagon-like peptide-1 receptor agonists reduced risk for venous thromboembolism among patients with type 2 diabetes, according to retrospective study results presented at ASH Annual Meeting and Exposition.

View more